BridgeMD
Tests treatment safety and results for Achondroplasia
Official title Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）
ClinicalTrials.gov ID: NCT06926491
What this study is testing
What is KK8398?
KK8398 is an investigational medicine, being studied as a potential treatment for achondroplasia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This trial will evaluate the efficacy of KK8398 on annualized height velocity after 52 weeks of repeated administration of KK8398 to patients with achondroplasia
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 18
You may be able to join if
- Patients who are between 2.5 and 17.5 years old of age at the time of provisional registration. Patients who meet certain criteria in terms of Tanner...
- Patients who have been diagnosed with achondroplasia through genetic testing.
You likely can't join if
- Patients who meet the criteria for a certain height determined by age and gender in the "Growth Chart for Patients with Achondroplasia" at the time...
- Patients who have received treatment with r-hGH or a CNP analogue within a certain period prior to the pre-enrollment examination.
- Patients who have had previous osteotomy or who are scheduled to undergo osteotomy or epiphyseal growth inhibition during the study period...
The study team makes the final eligibility decision.
Where it's taking place
- Ōbu, Aichi-ken, Japan
- Suita, Osaka, Japan
- Waizumi, Osaka, Japan
- Fuchū, Tokyo, Japan
- Yonago, Tottori, Japan
- Niigata, Japan
- Okayama, Japan
- Osaka, Japan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ōbu, Aichi-ken, Japan; Suita, Osaka, Japan; Waizumi, Osaka, Japan; Fuchū, Tokyo, Japan; Yonago, Tottori, Japan; Niigata, Japan and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.